(Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.
IMPORTANT SAFETY INFORMATION FOR PATIENTS
(Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.1
Do not use SANCUSO if you are allergic to granisetron or any of the other ingredients in SANCUSO.1
Tell your healthcare professional if you are pregnant, if you plan to become pregnant, or you are breastfeeding.1
Tell your healthcare professional if you have pain or swelling in stomach area (abdomen), or if you are allergic to medical adhesive tape, adhesive dressings, or other skin patches.1
Tell your healthcare professional about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Other medicines may affect how SANCUSO works. SANCUSO may also affect how your other medicines work.1
The medicine in SANCUSO (granisetron) may not work well and/or may affect your skin if exposed to direct sunlight and the light from sunlamps or tanning beds. While wearing the patch keep it covered with clothing if you will be in sunlight or near a sunlamp, including tanning beds. Keep the skin where SANCUSO was applied covered for another 10 days after the patch is taken off to protect from exposure to direct sunlight.1
You may see mild redness on the skin where the patch is removed. This redness should go away within three days. If redness continues, tell your healthcare professional. The most common side effect of SANCUSO is constipation.1
Tell your healthcare professional if you have any side effect that bothers you or that does not go away. This is not the only possible side effect of SANCUSO.1
For more information, ask your healthcare professional or pharmacist.
Fareston® (toremifene citrate) 60mg Tablets is a prescription medicine approved for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor–positive or unknown tumors.
WARNING: QT PROLONGATION
Fareston has been shown to cause a change in heart rhythm (QT prolongation). This change can lead to fainting, seizures, and/or death. Do not take Fareston if you were born with or have a history of irregular heartbeats. Do not take Fareston if you have low blood potassium levels or low blood magnesium levels that are currently not corrected by treatment. There are certain medicines that should not be taken with Fareston. Talk to your doctor about all the other medicines you are taking.
Important Safety Information
Do not take Fareston if you are allergic to Fareston or any of its ingredients. You should not take Fareston if you have a history of abnormal heart rhythms (arrhythmias), are taking other medicines that can result in abnormal heart rhythms, or were born with or have had any condition that causes abnormal heart rhythms. Do not take Fareston if you have a salt imbalance in the blood, especially low concentrations of potassium (hypokalemia) or low concentrations of magnesium in the blood (hypomagnesemia) that are currently not corrected by treatment.
Talk to your doctor before taking Fareston if you have bone metastasis or increased concentration of calcium in the blood (hypercalcemia) which may occur at the beginning of your treatment. Also talk to your doctor if you have a history of thickening of the womb lining. If you are pregnant, nursing, or may become pregnant, do not take Fareston, as it may cause fetal harm. You should not take Fareston if you have had or are at risk for getting blood clots in the legs, lungs, or eyes, as it may increase the risk of blood clots. If you have leg pain or warmth; swelling of the legs, hands or feet; chest pain; shortness of breath; or a sudden vision change, stop taking Fareston and call your doctor, as these may be signs of a blood clot. The most common side effects of Fareston are hot flashes, nausea, sweating, and vaginal discharge. To report suspected adverse reactions, contact ProStrakan, Inc. at (800) 305-FARESTON (1-800-305-3273), or the FDA at (800) FDA-1088 or visit www.fda.gov/medwatch.
SANCUSO [package insert]. Bridgewater, NJ: ProStrakan, Inc; 2012.
Fareston [package insert]. Bridgewater, NJ: ProStrakan, Inc; 2012.